Jim Foote, CEO of First Ascent Biomedical, is revolutionizing cancer care with an AI-driven, functional precision medicine platform. Inspired by…
OSLO, Norway, Oct. 15, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered…
Winning image of a common agricultural pest reveals the beauty and complexity of insects often overlooked in daily life MELVILLE,…
At ASHG, an early access customer from the London Health Sciences Center Research Institute will demonstrate the power of the…
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in…
Expands support and access by matching eligible patients to trials and guiding them through enrollment DUARTE, Calif., Oct. 15, 2025 /PRNewswire/…
Innovation meets rising need as liver disease rates climb nationwide RICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- A Roanoke woman…
RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to…
Jonathan Swerdlin, Co-Founder & CEO, Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit NEW YORK, Oct. 15,…
Breakthrough designation for Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) supports CAPS Medical's mission to transform tumor ablation into a…